Výsledky vyhledávání - "Jean Marie Billiouw"

Fibromuscular dysplasia – results of a multicentre study in Flanders

Autor: Marie De Groote, Bert Callewaert, Patricia Van der Niepen, Jean-Marie Billiouw, Tine De Backer, Jan Donck, An S. De Vriese, Frank Vermassen, Dimitri Hemelsoet

Publikováno v: Vasa. 46:211-218

Abstract. Background: Fibromuscular dysplasia (FMD) is an idiopathic, non-inflammatory, non-atherosclerotic vascular disease, resulting in focal narrowing of small and medium-sized arteries. Systematic recording of clinical data in central databases

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78bcf3d62054d27f35a78f7e4df9cd43
https://doi.org/10.1024/0301-1526/a000613

Zobrazit plný text záznamu

Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study

Autor: Jean Marie Billiouw, Jean Ducobu, Robert Lins, Yvon Carpentier, Gert A. Verpooten, Christian Tielemans, Björn Maes, Pierre Dupont, Jean Claude Stolear, Katelijne E. Matthys, Norbert Lameire, Max Dratwa, Patrick Peeters

Publikováno v: Clinical Nephrology. 62:287-294

BACKGROUND Patients with end-stage renal disease commonly present with an atherogenic lipid profile characterized by the accumulation of triglyceride-rich, apoprotein B-containing "remnant" lipoproteins, small dense low-density lipoprotein, and low l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f02aff7a5227a26b6669e8b3749419ed
https://doi.org/10.5414/cnp62287

Zobrazit plný text záznamu

Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)

Autor: Lorenzo Bacigalupo, Luis Martí-Bonmatí, Jean-Jacques Boffa, Joaquin Ferreiros, François Glowacki, Claire Rigothier, Olivier Rouvière, Bart Maes, Thierry Hannedouche, Gilbert Deray, Paolo Campioni, Daniel Alison, Daniel Devos, François Vrtovsnik, Jean-Marie Billiouw

Publikováno v: European radiology. 23(5)

To prospectively compare the renal safety of meglumine gadoterate (Gd-DOTA)-enhanced magnetic resonance imaging (MRI) to a control group (unenhanced MRI) in high-risk patients.Patients with chronic kidney disease (CKD) scheduled for MRI procedures we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffce2627acc07741609cd4d4599450eb
https://pubmed.ncbi.nlm.nih.gov/24432402

Zobrazit plný text záznamu

Immunogenicity and safety of an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: Results of two open, randomized, comparative trials

Autor: Jean-Marie Billiouw, Murielle Surquin, Olivier Mat, Serge Treille, Michel Jadoul, Dezider Kosa, Miroslav Ryba, Sophie Houard, Sherine Kuriyakose, Vladimir Polakovic, Jiri Vlasak, Maarten Leyssen, Gert A. Verpooten, Christian Tielemans, Ilona Mezei, Patrick Peeters, Michel Dhaene

Publikováno v: Vaccine

An investigational AS02v-adjuvanted hepatitis B (HB-AS02) was compared with a licensed conventional recombinant hepatitis B vaccine (HBVAXPRO; Sanofi Pasteur MSD, Lyon, France) in pre-dialysis, peritoneal dialysis and hemodialysis patients aged ≥18

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13e80cb5e7134e28253495583d632c40
https://hdl.handle.net/20.500.14017/a51d615d-8952-45d4-9858-f8cd6ed5a337

Zobrazit plný text záznamu

The enigma of hypertensive ESRD: observations on incidence and trends in 18 European, Canadian, and Asian-Pacific populations, 1998 to 2002

Autor: John H, Stewart, Margaret R E, McCredie, Sheila M, Williams, Stanley S, Fenton, Lilyanna, Trpeski, Stephen P, McDonald, Kitty J, Jager, Paul C W, van Dijk, Patrik, Finne, Staffan, Schon, Torbjorn, Leivestad, Hans, Løkkegaard, Jean-Marie, Billiouw, Reinhard, Kramar, Angela, Magaz, E, Vela, Maria J, Garcia-Blasco, G A, Ioannidis, Y N, Lim

Publikováno v: American journal of kidney diseases, 48(2), 183-191. W.B. Saunders Ltd

Background: Despite improved treatment of hypertension and decreasing rates of stroke and coronary heart disease, the reported incidence of hypertensive end-stage renal disease (ESRD) increased during the 1990s. However, bias, particularly from varia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0efdb98c8e1e8bd08cb47c793b2c8ffb
https://pubmed.ncbi.nlm.nih.gov/16860183

Zobrazit plný text záznamu

Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases

Autor: Raymond Vanholder, Norbert Lameire, Hans Schepkens, Jean-Marie Billiouw

Publikováno v: The American journal of medicine. 110(6)

Purpose: The beneficial effects of spironolactone are additive to those of ACE inhibitors among patients with heart failure and/or hypertension; however, it is essential to identify patients prone to develop serious hyperkalemia during combined treat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d78603b880880f5a08a19700cd918968
https://pubmed.ncbi.nlm.nih.gov/11705445

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání